预充式注射器市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

  • Report Code : TIPHE100001332
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 170
Buy Now

【研究报告】预灌封注射器市场规模预计将从2022年的66.9894亿美元增至2030年的150.0368亿美元;预计从 2022 年到 2030 年,该市场的复合年增长率将达到 10.6%。
市场洞察和分析师观点:
预充式注射器 (PFS) 是注射药物管理的最新辅助工具。制药公司和生物技术公司都在 PFS 中提供疫苗和蛋白质药物等产品。在过去的几十年里,PFS 已成为一种流行的药物输送方法。借助 PFS,护士和患者的药品给药过程可以更快、更安全、更轻松。慢性疾病患病率的增加和自注射注射装置的日益普及等因素正在推动市场的增长。另一方面,不断增加的产品召回阻碍了预充式注射器市场的增长。
增长动力:
慢性病患病率的增加推动预充式注射器市场增长
人口老龄化的不断加剧以及社会行为和生活方式的变化导致了一些常见的长期健康状况。根据世界卫生组织 (WHO) 的预测,到 2026 年底,慢性生活方式疾病的患病率预计将增加 57%。由于发展中国家人口预计将爆炸,新兴市场将受到最严重的打击。随着城市化进程的加快,人们更倾向于久坐的生活方式,这会导致类风湿性关节炎、糖尿病等疾病。糖尿病是21世纪全球主要健康问题之一。根据国际糖尿病联盟(IDF)的数据,2019年北美糖尿病患者人数约为4600万,预计到2045年将达到6200万。预测期内疾病患病率增加约35% .
克罗恩病、多发性硬化症和心血管疾病等其他慢性疾病需要频繁给药以进行疾病管理和治疗。根据世界卫生组织的数据,心血管疾病是导致死亡的主要原因——每年有近 1790 万人因心血管疾病死亡。它已成为全球大量患者群体注射给药的新标准。此外,这些预充式注射器只需很少的培训即可供大量患者使用,并且不需要医疗保健专业人员的持续帮助,因此预充式注射器主要在专业医疗保健环境以及家庭医疗保健环境中采用,从而推动了预充式注射器的发展市场增长。
战略见解
报告细分和范围:
预充式注射器市场根据类型、材料、产品类型、应用、分销渠道和地理位置进行细分。
预灌封注射器市场按类型分为一次性预灌封注射器和可重复使用预灌封注射器。 2022年,一次性预灌封注射器细分市场占据更大的市场份额,预计2022-2030年复合年增长率更快。根据材料,预灌封注射器市场分为玻璃预灌封注射器和塑料预灌封注射器。 2022年,玻璃预灌封注射器细分市场占据更大的市场份额,而塑料预灌封注射器细分市场预计在2022-2030年期间复合年增长率更快。根据产品类型,预灌封注射器市场分为单室和多室。 2022年,单腔细分市场占据更大的市场份额,预计多腔细分市场在2022-2030年期间复合年增长率更快。根据应用,预充式注射器市场分为癌症、糖尿病、自身免疫性疾病、传染病等。 2022年,其他细分市场占据最大的市场份额,预计传染病细分市场在2022年至2030年期间复合年增长率最快。根据分销渠道,预灌封注射器市场分为医院药房、零售药房和在线渠道。 2022年,医院药房领域占据最大的市场份额,预计2022-2030年复合年增长率最快。
细分分析:
预灌封注射器市场按类型分为一次性预灌封注射器和可重复使用预灌封注射器。 2022年,一次性预灌封注射器细分市场占据更大的市场份额,预计2022-2030年复合年增长率更快。
预充式一次性注射器设计为一次性使用,用后即被丢弃,以减少污染和感染的风险。这些注射器在医疗保健环境中用于注射药物、疫苗和其他注射剂。它们还可以用于家庭医疗保健环境中,定期自我注射注射剂。预充式一次性注射器有胰岛素注射器、过敏注射器、结核菌素注射器等不同类型,且尺寸各异。此外,预充式自动注射器的使用增加产生了对一次性预充式注射器的需求,因为它们作为单剂量出售。此外,大量人群中过敏和感染病例的增加,加上世界各地卫生部和其他监管机构制定的严格安全指南,预计将推动一次性预充式注射器的增长。
按类型划分的预充式注射器市场 – 2022 年和 2030 年
根据材料,预灌封注射器市场分为玻璃预灌封注射器和塑料预灌封注射器。 2022年,玻璃预灌封注射器细分市场占据更大的市场份额,而塑料预灌封注射器细分市场预计在2022-2030年期间复合年增长率更快。玻璃因其稳定且不发生反应而被广泛用于存储;然而,主要缺点是其脆弱性。用于制造预灌封注射器的玻璃应由水解 I 类硼硅酸盐玻璃制成,其转变温度为 565°C。
玻璃预灌封注射器有两种类型。
油硅化注射器:在这种类型中在预填充注射器系统中,橡胶与玻璃表面直接接触,随着时间的推移,会导致更高的挖掘力和污染的机会。烘烤硅胶注射器:这些背衬硅胶注射器为威尔士玻璃筒提供一致的涂层。储存期间挖掘力保持较低。根据产品类型,预充式注射器市场分为单室和多室。 2022年,单室细分市场占据更大的市场份额,预计多室细分市场在2022-2030年期间复合年增长率更快。
单室预充式注射器用于注射疫苗、药品和生物制品。这些注射器专为特定剂量的药物而设计,并且可以通过不同的销售渠道轻松获得。与多室预充式注射器相比,它们易于操作和使用。制造商致力于进一步开发单室预充式注射器技术,通过使用可伸缩针头和 RFID 或 NFC 系统来提高患者安全,从而防止针刺伤害。这些类型的注射器主要用于以液体形式给药的药物,由于它们由单剂量药物组成,因此感染和污染风险较低。
根据应用,预充式注射器市场被细分癌症、糖尿病、自身免疫性疾病、心血管疾病、传染病等。 2022年,其他细分市场占据最大的市场份额,预计传染病细分市场在2022年至2030年期间复合年增长率最快。
传染病的患病率很高,包括人类免疫缺陷病毒(HIV)、肝炎、疟疾、结核病 (TB) 和世界各地的其他传染病。艾滋病毒仍然是世界范围内的一个重大公共卫生问题。根据联合国艾滋病毒/艾滋病联合规划署 (UNAIDS) 的数据,2021 年,全世界约有 3840 万人感染艾滋病毒。此外,肝炎是推动预充式注射器市场的另一个主要因素。据世界卫生组织 (WHO) 统计,全球约有 5800 万人患有慢性丙型肝炎感染,每年新增病例 150 万例。此外,约有 320 万青少年和儿童感染丙型肝炎。
市场参与者正在推出用于治疗传染病的预充式注射器,作为一种简单、方便的给药方法。 2023 年 4 月,CSL Behring 获得美国食品和药物管理局 (FDA) 批准用于 Hizentra(免疫球蛋白皮下[人]20% 液体)的 50 ml/10 gm 预填充注射器。该公司提供全系列尺寸的预充式注射器,以满足慢性炎症性脱髓鞘性多发性神经病 (CIDP) 或原发性免疫缺陷 (PI) 患者的需求。
2021 年 4 月,诺华 Xolair(奥马珠单抗)自我注射剂获得 FDA 批准使用预装注射器,适用于适合患者的所有适应症。 Xolair 是 FDA 批准的靶向和阻断免疫球蛋白 E (IgE) 的生物制剂,用于治疗重度和中度持续性过敏性哮喘、慢性特发性荨麻疹 (CIU) 和鼻息肉。
根据分销渠道,预充式注射器市场细分为医院药房、零售药房、网上渠道。 2022年,医院药房领域占据最大的市场份额,预计2022-2030年复合年增长率最快。医院药房是医疗保健系统的重要组成部分。这些药房位于医院内,是处方产品的主要配送中心。他们为在相应医院接受治疗或护理的患者提供药物和其他医药产品。这些药房负责确保安全、准确地储存、准备和分发药物以供医院使用。他们还负责提供临床药学服务以支持患者护理。此外,医院药房可以从事药物管理、药物使用审查以及对患者和医疗保健提供者的药物教育。医院药房是预充式注射器最常见的分销渠道之一,因为患者每次就诊后都可以轻松购买预充式注射器中的处方药物。
区域分析 - 预充式注射器市场:
根据地理位置,预充式注射器市场分为五个主要区域:北美、欧洲、亚太地区、南美和中美洲以及中东和非洲。 2022年,北美占据预灌封注射器市场最大份额。预计 2022 年至 2030 年,亚太地区将成为全球预灌封注射器市场复合年增长率最高的地区。
北美预灌封注射器市场分为美国、加拿大和墨西哥。该地区预充式注射器市场的增长主要是由于自注射注射器的采用增加以及该地区用于治疗慢性疾病的家庭医疗保健的激增。
根据糖尿病研究所的数据, 2022 年,美国糖尿病患者约为 3730 万人(占人口的 11.3%)。美国有近 2870 万人被诊断患有糖尿病,约 860 万人患有未确诊的糖尿病。此外,美国每年诊断出约 140 万糖尿病病例。根据美国疾病控制与预防中心的数据,2020 年,约 8800 万成年人患有糖尿病前期,占美国成年人口的 34.5%。据耶鲁大学研究人员称,到 2022 年,美国约有 3000 万人患有糖尿病,约 700 万人需要每日注射胰岛素。
美国对不孕不育治疗的需求不断增加。据 CDC 称,到 2022 年,约 22% 的已婚夫妇(其中女性年龄超过 30 岁)在怀第一个孩子方面存在问题。为了克服不孕问题,市场上可以通过预充式注射器进行各种治疗。 2023 年 7 月,费森尤斯·卡比 (Fresenius Kabi) 推出了醋酸加尼瑞克注射液 (Ganirelix Acetate Injection),这是一种仿制生育药物,采用 250 微克/0.5 毫升预装注射器包装,作为该公司在女性健康领域扩张的一部分。因此,糖尿病和其他疾病的患病率不断上升,以及产品推出的激增,预计将推动美国预充式注射器市场的增长。
行业发展和未来机遇 - 预充式注射器市场:
各种举措预充式注射器市场领先企业采取的措施如下:
2023 年 4 月,Delta Med 集团与领先的预充式注射器制造商 DBM 合作。 Delta Med Group 和 DBM 将扩大产品组合,从高度互补的产品和研发能力中获益,提高服务客户的能力。此次合作将产生显着的协同效应,并推动合并后实体的增长轨迹。 2022 年 10 月,Hikma Pharmaceuticals PLC (Hikma) 在美国推出预充式注射器 (PFS) 形式的氯化琥珀胆碱注射液 (USP)。 100 mg/5 ml PFS是首个经FDA批准投放市场的PFS。 2022年6月,药明生物在中国启动了预充式注射器药品生产设施。新工厂的 PFS 产能为每年 1700 万台。最大灌装速度可达400 PFS/min,可支持每年生产1700万支注射器的药品。 2022年2月,武田获得美国食品药品监督管理局(FDA)批准TAKHZYRO(lanadelumab-flyo)注射剂单剂量预充式注射器(PFS)用于预防12岁及以上患者遗传性血管性水肿(HAE)的发作。 PFS 已准备好使用,并且比当前的 TAKHZYRO 小瓶注射剂需要更少的准备,同时减少了供应和浪费。2022 年 1 月,Owen Mumford Ltd. 的一个部门 Owen Mumford Pharmaceutical Services 获得了 UniSafe 1 ml 安全装置的批准,用于预充式注射器作为亚洲的组合产品。在欧洲,UniSafe 1 ml 已获得监管部门批准,该产品作为与治疗类风湿关节炎药物的组合产品进行商业化销售。 2021 年 3 月,SK bioscience 推出了一种名为“SKYZoster® Ini”的新型带状疱疹疫苗。新推出的预灌封注射器类型 SKYZoster 比目前将注射用水和冻干疫苗混合然后转移回注射器的肌肉注射类型更方便。
竞争格局和主要公司 – 预灌封注射器市场:
Gerresheimer AG、Schott Group、Nipro Medical Corporation、BD、Baxter International Inc.、Terumo、YPSOMED、Weigao group、B Barun 和 Deltamed 是预灌封注射器市场上的知名公司。这些公司专注于新技术、现有产品进步和地域扩张,以满足全球不断增长的消费者需求。
在准备世界卫生组织 (WHO) 的预充式注射器市场报告时提到的一些主要主要和次要来源,国际糖尿病联合会 (IDF)、国家卫生研究院 (NIH)、迪拜卫生局、国家医学图书馆 (NLM)、2020 年卫生研究政策和系统、2021 年美国癌症协会、Globocan 和疾病控制与预防中心(CDC)。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the different segments in the prefilled syringe market?

The prefilled syringe market is analyzed based on type, material, product type, application, distribution cahnnel.
The prefilled syringe market, by type, is bifurcated into disposable prefilled syringes and reusable prefilled syringes. Based on material, the prefilled syringe market is bifurcated into glass prefilled syringes and plastic prefilled syringes. Based on product type, the prefilled syringe market is bifurcated into single chamber and multi-chamber. Based on application, the prefilled syringe market is segmented into cancer, diabetes, autoimmune disease, infectious diseases, and others. Based on end user, the prefilled syringe market is segmented into hospital pharmacy, retail pharmacy, and online channel

Who are the major players in the prefilled syringe market?

The prefilled syringe market majorly consists of the players such as Gerresheimer AG, Schott Group, Nipro Medical Corporation, BD, Baxter International Inc., Terumo, YPSOMED, Weigao group, B Barun , Deltamed.

What are the driving factors for the global prefilled syringe market worldwide?

The growth of the global prefilled syringe market is attributed to a few key factors, such as the increasing prevalence of chronic disorders and growing adoption of self-injecting parenteral devices.

What are prefilled syringe?

Prefilled syringes (PFS) are the most recent aids for administering injectable medicines. Both pharmaceutical and biotech companies deliver products such as vaccines and protein medicines in PFS. In the past few decades, PFS has become a very popular method of drug delivery. With a PFS, the process of administering a drug product can be quicker, safer, and easier for nurses and patients.

Which region is dominating the prefilled syringe market?

The North American region dominates the prefilled syringe market share. Asia Pacific is anticipated to register the highest CAGR during the forecast period.

The List of Companies - Prefilled Syringe Market

  1. Gerresheimer AG
  2. Schott Group
  3. Nipro Medical Corporation
  4. BD
  5. Baxter International Inc.
  6. Terumo
  7. YPSOMED
  8. Weigao group
  9. B Barun
  10. Deltamed      

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports